McGill University
Channels
McGill University News and Events
Enter your keywords
Home
News
Recommendations for the Use of the H1N1 Flu Vaccine
Published:
13
November
2009
Facebook
LinkedIn
Tweet Widget
The Government of Canada has authorized the use of the H1N1 flu vaccine, which is called AREPANRIX and is manufactured by GlaxoSmithKline (GSK).
Related Links
Recommendations for the Use of the H1N1 Flu Vaccine on Public Health Agency of Canada - H1N1 Influenza Updates
Category:
McGill University Health Centre (MUHC)
MUHC
Last updated:
Mon, 09/03/2012 - 10:10
Source Site:
/channels
Back to top